Stomach and colorectal cancer: AI identifyies patients for immunotherapy • healthcare-in-europe.com
MSI-H Biomarker | Colorectal Cancer Alliance
The Importance of MSI Status
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
Immunotherapy Combination Approved for Colorectal Cancer - NCI
Microsatellite Instability | Caris Life Sciences
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes: Cell
Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
A molecular portrait of microsatellite instability across multiple cancers | Nature Communications
Distribution of microsatellite instability (MSI) status across cancer... | Download Scientific Diagram
Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients - Aasebø - 2019 - Cancer Medicine - Wiley Online Library
MSI/MSS Colorectal Cancers - TRanslational ONCOlogy
Understanding MSI-High and DNA Mismatch Repair - CancerConnect
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches | SpringerLink
Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment | Journal for ImmunoTherapy of Cancer
Frontiers | Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches
Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor | Anticancer Research
Microsatellite instability - Wikipedia
MSI-H Biomarker | Colorectal Cancer Alliance
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers | SpringerLink
Presence of MSI-H, MMR-D Predicts Lynch Syndrome Across Tumor Types
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers | SpringerLink
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
